Developer docs
API playgroundTry for free, no card

Search company profiles

Global Health Technologies Coalition

Full company profile

uuid025r5pr

Namestring
Global Health Technologies Coalition
Legal namestring
PATH, as secretariat of the Global Health Technologies Coalition
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Global Health Technologies Coalition (GHTC) is a nonprofit advocacy coalition founded in 2009 and operated by PATH as its secretariat from the Washington, DC area. It does not develop or sell products; rather, it convenes 55+ member organizations — including nonprofits (PATH, Gates Foundation, CEPI, CARB-X, DNDi, TB Alliance, IVI), academic institutions, and aligned businesses — to advocate for US policy solutions that accelerate the development of and access to vaccines, drugs, diagnostics, and other essential health technologies for global health needs. Its primary constituents are US policymakers (NIH, CDC, USAID, BARDA, Congress) and the broader global health R&D community, with measurable downstream impact delivered through member partnerships such as the nOPV2 polio vaccine (1 billion+ doses delivered) and NEST360 (500,000+ newborn deliveries supported annually).

The coalition's operating model is community-led advocacy rather than commercial. It is funded through membership contributions and donor support, with no disclosed pricing or product revenue. Its go-to-market consists of publishing policy briefs and the Breakthroughs Blog, maintaining an R&D dictionary and the Innovation Interrupted tool (which documents recent US grant terminations), organizing the biennial Innovating for Impact Awards since 2017, and conducting direct engagement with US government agencies and Congressional offices. Distribution runs through its website (ghtcoalition.org) and active social media presence on X, Facebook, LinkedIn, YouTube, and Bluesky.

GHTC has no proprietary technology, patents, or AI capabilities; its technology footprint is limited to standard web publishing and email/newsletter infrastructure. Its value proposition rests on being the only broad-based coalition singularly focused on advocating for increased and effective US public funding for global health R&D, with a member ecosystem spanning vaccines, drugs, diagnostics, and health technologies across multiple continents.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMississauga, Canada
HQ citystring
Mississauga
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
global health policy advocacy, health research funding, vaccine development policy, nonprofit coalition advocacy, international health R&D
Industry4 codes
1Public–Private Partnerships (PPPs) for Global Health
CodeHLAJAOADPrimaryYes
2Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)
CodeHLAJAOAMPrimaryNo
3Global Health Research, Evidence & Technical Assistance Organizations
CodeHLAJAKANPrimaryNo
4Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryNo
NAICS code2 codes
  • Social Advocacy Organizations8133
  • Business Associations81391
SIC code2 codes
  • Services-Membership Organizations8600
  • Services-Health Services8000
Product category
Health Policy Advocacy
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Coalition Operations
TypeSubscription Recurring
Description

GHTC is operated as a nonprofit coalition with PATH serving as its secretariat. The coalition is funded through membership contributions and support from member organizations and donor governments. Specific revenue details are not publicly disclosed.

ghtcoalition.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

GHTC is a nonprofit advocacy coalition that brings together nonprofits, academic institutions, and aligned businesses to advocate for policy solutions that accelerate the development of vaccines, drugs, diagnostics, and other essential health technologies for global health needs. The coalition operates as PATH's secretariat program, offering policy advocacy, coalition coordination, member communications, and the Innovating for Impact Awards program to recognize partnerships and policymakers driving global health innovation.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • The coalition honors outstanding partnerships and policymakers through the biennial Innovating for Impact Awards, recognizing 9 cycles of honorees since 2017
+3 more records
Product overview1 text field

Global Health Technologies Coalition (GHTC) is a nonprofit advocacy coalition—not a product company—that works to save and improve lives globally through advocating for increased research and development of vaccines, drugs, diagnostics, and other essential health technologies. GHTC does not develop or sell products directly; instead, it serves as an advocacy organization that brings together nonprofits, academic institutions, and aligned businesses to advocate for policy solutions that accelerate the creation of fit-for-purpose health tools. The coalition's primary offerings include policy advocacy, the annual Innovating for Impact Awards program recognizing outstanding R&D partnerships and policymakers, a resource library, news and insights content, and membership coordination services connecting organizations committed to advancing health equity through innovation.

Product and service1 record
1GHTC Coalition Membership
CategoryCoalition Membership Services
Description

Membership in the Global Health Technologies Coalition coalition, open to eligible organizations committed to advancing health equity through innovation. Members include nonprofits, academic institutions, and aligned businesses working across vaccines, drugs, diagnostics, and other health technologies.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership52 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PATH serves as the secretariat for GHTC, providing operational support and hosting the coalition. GHTC is operated by PATH, which is a global organization accelerating health equity by bringing together public institutions, businesses, social enterprises, and investors to solve pressing health challenges.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit organization working to reduce the global burden of infectious disease and avert future pandemics by accelerating the development of vaccines, treatments, and medical interventions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Investment firm financing promising life science technologies for high-burden public health challenges, focusing on neglected infectious diseases, maternal and child health, and reproductive health.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Largest international scientific organization of experts dedicated to reducing the worldwide burden of tropical infectious diseases and improving global health, with over 100 years of history.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global community of 38,000+ members shaping the future of microbial sciences, with expertise in publishing, convening, advocacy, and professional development.

6AVAC
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit using education, policy analysis, advocacy, and global collaborations to accelerate ethical development and global access to effective HIV prevention options.

ghtcoalition.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Unique global health community with 70+ member organizations including academic institutions, technology companies, foundations, and nonprofits united by dedication to global health innovation and equity.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

One of the largest global medical technology companies, developing innovative technology, services, and solutions to advance clinical therapy for patients and clinical process for healthcare providers.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Major philanthropic foundation guided by the belief that every life has equal value, working to help all people lead healthy, productive lives in developing countries and globally.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit dedicated to achieving breakthroughs in humanity's capability to prevent, mitigate, and suppress pandemics by providing actionable roadmaps and tackling bottlenecks to progress.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research company bringing world-class structural biology, medicinal chemistry, and computational biology to create solutions for areas with high unmet need, including novel antibiotics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Local Zambian NGO committed to answering key health-related research questions, supporting local ownership of high-quality healthcare research and services within the Zambian public health system.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Innovative global partnership launched in 2017 to develop vaccines to stop future epidemics, accelerating vaccine development against emerging infectious diseases with equitable access.

14Coalition for Health Research and Development (CHReaD)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Network hosted at Amref Health Africa in Kenya, bringing together civil society, research institutions, academia, government, and private sector to promote health research and innovation in East Africa.

ghtcoalition.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Company founded on bringing high-quality molecular diagnostics to underserved areas, guided by vision of lowering healthcare costs through increasing access to gold-standard PCR tools.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Global nonprofit public-private partnership dedicated to accelerating development of innovative products to prevent, diagnose, and treat dangerous bacterial infections, created by US and Wellcome in 2016.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global development organization focusing on needs of youth generation, committed to health information access and reproductive health initiatives with presence in Ethiopia, Kenya, Tanzania, and Uganda.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

First and only NGO in Tanzania working with government and private stakeholders for premature babies, having donated medical equipment worth $435,000+ and saved 13,000+ premature babies' lives.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Patient-needs driven, not-for-profit R&D organization delivering new treatments for neglected diseases including leishmaniasis, sleeping sickness, Chagas disease, and pediatric HIV.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Proven leader in global fight to end HIV and AIDS with advocacy for children, having achieved significant progress through research, global advocacy, and health systems strengthening.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global organization mobilizing resources and relationships for people to lead full and healthy lives, working in 60+ countries with local leaders to advance social and economic equity.

22FIND
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global alliance for diagnostics seeking to ensure equitable access to reliable diagnosis, working to save 1 million lives through accessible, quality diagnosis and save $1 billion in healthcare costs.

ghtcoalition.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance advancing global health equity by promoting collaboration among business, academia, nonprofits, and government within Georgia and linking them with US and international partners.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Not-for-profit organization developing new treatments for drug-resistant infections, created to ensure everyone who needs antibiotics receives effective and affordable treatment regardless of where they live.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Established in 1972, the leading membership organization supporting and connecting advocates, implementers, and stakeholders around global health priorities worldwide.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Japan-based international public-private partnership between Japanese government, pharmaceutical companies, Gates Foundation, Wellcome, and UNDP, investing in neglected disease R&D.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

African health sector knowledge powerhouse combining deep African roots with global reach, focusing on transforming Africa's private health sector for positive change.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global not-for-profit ensuring development of safe, effective, accessible preventive HIV vaccines, working with partners in 25 countries to research, design, and develop AIDS vaccine candidates.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit research and policy organization known for building the gold-standard G-FINDER database of global health R&D funding and comprehensive product pipeline datasets.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global network uniting civil society organizations committed to prevention, treatment, and control of infectious diseases, advocating for stronger policies and increased resources.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Organization of physicians, scientists, and health professionals dedicated to promoting health through excellence in infectious diseases research, education, and patient care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Product development partnership based in Liverpool working to facilitate development of novel public health insecticides to combat insecticide resistance in malaria-carrying mosquitoes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dedicated to developing HIV prevention products and sexual and reproductive health technologies for women, making them available where urgently needed.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Team with 27+ years working at intersection of international development, public health, and private sector, with 19 years active in malaria community.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit intergovernmental organization established in 1997 with 36 countries and WHO on its treaty, focused on making vaccines available for world's most vulnerable.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Leading product development partnership in antimalarial drug R&D, working to reduce malaria burden through discovering, developing, and facilitating delivery of new antimalarial drugs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founded in 2010, working to increase access to and facilitate development of innovative medicines for low- and middle-income countries through voluntary licensing and patent pooling.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance dedicated to advancing North Carolina as a center of global health by fostering collaboration, innovation, and next-generation leadership in the state and region.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

US partner of Institut Pasteur in Paris, a world-class biomedical research center with 10 Nobel Prizes, dedicated to studying and combating infectious diseases.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Global organization accelerating health equity by bringing together public institutions, businesses, social enterprises, and investors, developing and scaling solutions including vaccines, drugs, devices, and diagnostics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Conducts research to address critical health and development issues, helping people plan families, avoid HIV infection, and empowering girls, with work in 50+ countries.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit consumer advocacy organization with 500,000 members and supporters, championing the public interest and defending democracy in halls of power.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Youth-led nonprofit working on sexual and reproductive health and HIV/AIDS prevention through youth empowerment, health education, social entrepreneurship, and ICT for health.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance advocating for science, discovery, and innovation to achieve better health, urging Congress to increase funding for NIH, CDC, FDA, and other agencies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading advocate for expanding vaccine access and uptake globally, advancing vaccine R&D, and amplifying vaccine knowledge, with two decades of experience.

46South Africa Health Technologies Advocacy Coalition (SAHTAC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Coalition advocating for enabling environment for health R&D and access to lifesaving technologies, supporting evidence-based policy change and improved funding coordination.

ghtcoalition.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Policy and advocacy action tank headquartered in Dakar, Senegal, dedicated to catalyzing leadership and policy change for sustainable development across Africa.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Nonprofit dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis through innovative science and global partnerships.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Independent activist and community-based research and policy think tank committed to racial, gender, and LGBTQ+ equity and fighting to end HIV, TB, and hepatitis C.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

African nonprofit created to foster competitive pharmaceutical manufacturing sector in Africa, partnering with regulators, purchasers, funders, and manufacturers.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance strategically connecting, expanding, and strengthening global health community to advance health equity, connecting 60+ organizational members across sectors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

For nearly 30 years, 10+ billion temperature monitoring devices have helped healthcare workers immunize children, working with WHO, UNICEF, Gavi, and US government to improve vaccine transport and storage.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Founded in 1972, Global Health Council is a leading membership organization supporting advocates, implementers, and stakeholders around global health priorities. It is a direct peer — both are membership-driven US-based advocacy coalitions operating in the global health policy space, and GHTC is itself a member of GHC.

TypeDirect peer
Description

Alliance advocating for science, discovery, and innovation to achieve better health by urging Congress to increase funding for NIH, CDC, FDA, and other agencies. Closely comparable as a US-focused advocacy coalition pushing for increased federal R&D funding — overlapping member ecosystems and advocacy targets with GHTC.

TypeDirect peer
Description

Leading advocate for expanding vaccine access and uptake globally, advancing vaccine R&D, and amplifying vaccine knowledge. Comparable as a global health advocacy and product development organization with a strong US policy voice; current GHTC member.

TypeDirect peer
Description

Independent activist and community-based research and policy think tank fighting to end HIV, TB, and hepatitis C. Comparable as a health R&D policy advocacy organization; a current GHTC member but also a peer in global health advocacy targeting similar policymakers.

TypeRegional player
Description

Policy and advocacy action tank headquartered in Dakar, Senegal, catalyzing leadership and policy change for sustainable development across Africa. Comparable as a health R&D advocacy organization focused on enabling environments and policy reform; current GHTC member.

TypeDirect peer
Description

Nonprofit research and policy organization behind the G-FINDER database tracking global health R&D funding. Direct peer — produces the evidence base GHTC uses for advocacy and operates in the same global health R&D policy ecosystem; current GHTC member.

TypeDirect peer
Description

Largest international scientific organization dedicated to reducing the worldwide burden of tropical infectious diseases. Comparable as a global health R&D–adjacent membership/advocacy organization; a current GHTC member operating in adjacent scientific advocacy.

TypeBroad incumbent
Description

Nonprofit consumer advocacy organization with 500,000+ members championing public interest issues including access to medicines and against pharmaceutical monopolies. Comparable in operating a US-focused policy advocacy coalition model, though much broader in scope than GHTC's global health R&D focus.

9Bay Area Global Health Alliance
TypeRegional player
Description

Regional global health alliance with 70+ member organizations in the Bay Area. Comparable as a multi-stakeholder global health coalition model, though regionally focused; a current GHTC member and structural peer in coalition-based global health advocacy.

TypeRegional player
Description

Alliance strategically connecting 60+ organizational members across sectors in the Pacific Northwest to advance health equity. Comparable multi-stakeholder global health coalition model with strong US policy and member engagement; a current GHTC member.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Global Health Technologies Coalition

Health Policy Advocacyghtcoalition.org

What Global Health Technologies Coalition does

Global Health Technologies Coalition (GHTC) is a nonprofit advocacy coalition founded in 2009 and operated by PATH as its secretariat from the Washington, DC area. It does not develop or sell products; rather, it convenes 55+ member organizations — including nonprofits (PATH, Gates Foundation, CEPI, CARB-X, DNDi, TB Alliance, IVI), academic institutions, and aligned businesses — to advocate for US policy solutions that accelerate the development of and access to vaccines, drugs, diagnostics, and other essential health technologies for global health needs. Its primary constituents are US policymakers (NIH, CDC, USAID, BARDA, Congress) and the broader global health R&D community, with measurable downstream impact delivered through member partnerships such as the nOPV2 polio vaccine (1 billion+ doses delivered) and NEST360 (500,000+ newborn deliveries supported annually).

The coalition's operating model is community-led advocacy rather than commercial. It is funded through membership contributions and donor support, with no disclosed pricing or product revenue. Its go-to-market consists of publishing policy briefs and the Breakthroughs Blog, maintaining an R&D dictionary and the Innovation Interrupted tool (which documents recent US grant terminations), organizing the biennial Innovating for Impact Awards since 2017, and conducting direct engagement with US government agencies and Congressional offices. Distribution runs through its website (ghtcoalition.org) and active social media presence on X, Facebook, LinkedIn, YouTube, and Bluesky.

GHTC has no proprietary technology, patents, or AI capabilities; its technology footprint is limited to standard web publishing and email/newsletter infrastructure. Its value proposition rests on being the only broad-based coalition singularly focused on advocating for increased and effective US public funding for global health R&D, with a member ecosystem spanning vaccines, drugs, diagnostics, and health technologies across multiple continents.

Global Health Technologies Coalition firmographics

Firmographics
Name
Global Health Technologies Coalition
Legal name
PATH, as secretariat of the Global Health Technologies Coalition
Website
https://ghtcoalition.org
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Global Health Technologies Coalition industry classification

Industry
Product category
Health Policy Advocacy
NAICS
Social Advocacy Organizations (8133), Business Associations (81391)
SIC
Services-Membership Organizations (8600), Services-Health Services (8000)
akta.pro primary industry
Public–Private Partnerships (PPPs) for Global Health (HLAJAOAD)
akta.pro secondary industries
Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

  • Global health policy advocacy
  • Health research funding
  • Vaccine development policy
  • Nonprofit coalition advocacy
  • International health R&D

Where Global Health Technologies Coalition is headquartered

Location

Headquarters

HQ city
Mississauga
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Global Health Technologies Coalition business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Coalition Operations: GHTC is operated as a nonprofit coalition with PATH serving as its secretariat. The coalition is funded through membership contributions and support from member organizations and donor governments. Specific revenue details are not publicly disclosed.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Global Health Technologies Coalition product offering

Product offering

Core offering

GHTC is a nonprofit advocacy coalition that brings together nonprofits, academic institutions, and aligned businesses to advocate for policy solutions that accelerate the development of vaccines, drugs, diagnostics, and other essential health technologies for global health needs. The coalition operates as PATH's secretariat program, offering policy advocacy, coalition coordination, member communications, and the Innovating for Impact Awards program to recognize partnerships and policymakers driving global health innovation.

Product overview

Global Health Technologies Coalition (GHTC) is a nonprofit advocacy coalition—not a product company—that works to save and improve lives globally through advocating for increased research and development of vaccines, drugs, diagnostics, and other essential health technologies. GHTC does not develop or sell products directly; instead, it serves as an advocacy organization that brings together nonprofits, academic institutions, and aligned businesses to advocate for policy solutions that accelerate the creation of fit-for-purpose health tools. The coalition's primary offerings include policy advocacy, the annual Innovating for Impact Awards program recognizing outstanding R&D partnerships and policymakers, a resource library, news and insights content, and membership coordination services connecting organizations committed to advancing health equity through innovation.

Differentiator

Problem solved

Functional benefit

Products and services

  • GHTC Coalition Membership Membership in the Global Health Technologies Coalition coalition, open to eligible organizations committed to advancing health equity through innovation. Members include nonprofits, academic institutions, and aligned businesses working across vaccines, drugs, diagnostics, and other health technologies.

Quantifiable outcome

  • The coalition honors outstanding partnerships and policymakers through the biennial Innovating for Impact Awards, recognizing 9 cycles of honorees since 2017
  • +3 more outcomes

Companies that use Global Health Technologies Coalition

Customer profile

Segments2 records

Ideal customer profiles2 records

Global Health Technologies Coalition technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Global Health Technologies Coalition partnerships and signals

Strategic signal

Partnerships

52 partnerships are on record, tiered core and flagship.

  • PATHcoreStrategic or Co-development PartnerPATH serves as the secretariat for GHTC, providing operational support and hosting the coalition. GHTC is operated by PATH, which is a global organization accelerating health equity by bringing together public institutions, businesses, social enterprises, and investors to solve pressing health challenges.
  • 1Day SoonercoreStrategic or Co-development PartnerNonprofit organization working to reduce the global burden of infectious disease and avert future pandemics by accelerating the development of vaccines, treatments, and medical interventions.
  • Adjuvant CapitalcoreStrategic or Co-development PartnerInvestment firm financing promising life science technologies for high-burden public health challenges, focusing on neglected infectious diseases, maternal and child health, and reproductive health.
  • American Society of Tropical Medicine and Hygiene (ASTMH)coreStrategic or Co-development PartnerLargest international scientific organization of experts dedicated to reducing the worldwide burden of tropical infectious diseases and improving global health, with over 100 years of history.
  • ASMcoreStrategic or Co-development PartnerGlobal community of 38,000+ members shaping the future of microbial sciences, with expertise in publishing, convening, advocacy, and professional development.
  • AVACcoreStrategic or Co-development PartnerNonprofit using education, policy analysis, advocacy, and global collaborations to accelerate ethical development and global access to effective HIV prevention options.
  • Bay Area Global Health AlliancecoreStrategic or Co-development PartnerUnique global health community with 70+ member organizations including academic institutions, technology companies, foundations, and nonprofits united by dedication to global health innovation and equity.
  • BDcoreStrategic or Co-development PartnerOne of the largest global medical technology companies, developing innovative technology, services, and solutions to advance clinical therapy for patients and clinical process for healthcare providers.
  • Bill & Melinda Gates FoundationflagshipStrategic or Co-development PartnerMajor philanthropic foundation guided by the belief that every life has equal value, working to help all people lead healthy, productive lives in developing countries and globally.
  • Blueprint BiosecuritycoreStrategic or Co-development PartnerNonprofit dedicated to achieving breakthroughs in humanity's capability to prevent, mitigate, and suppress pandemics by providing actionable roadmaps and tackling bottlenecks to progress.
  • BugworkscoreStrategic or Co-development PartnerResearch company bringing world-class structural biology, medicinal chemistry, and computational biology to create solutions for areas with high unmet need, including novel antibiotics.
  • Centre for Infectious Disease Research in Zambia (CIDRZ)coreStrategic or Co-development PartnerLocal Zambian NGO committed to answering key health-related research questions, supporting local ownership of high-quality healthcare research and services within the Zambian public health system.
  • Coalition for Epidemic Preparedness Innovations (CEPI)flagshipStrategic or Co-development PartnerInnovative global partnership launched in 2017 to develop vaccines to stop future epidemics, accelerating vaccine development against emerging infectious diseases with equitable access.
  • Coalition for Health Research and Development (CHReaD)coreStrategic or Co-development PartnerNetwork hosted at Amref Health Africa in Kenya, bringing together civil society, research institutions, academia, government, and private sector to promote health research and innovation in East Africa.
  • Co-DiagnosticscoreStrategic or Co-development PartnerCompany founded on bringing high-quality molecular diagnostics to underserved areas, guided by vision of lowering healthcare costs through increasing access to gold-standard PCR tools.
  • CARB-XflagshipStrategic or Co-development PartnerGlobal nonprofit public-private partnership dedicated to accelerating development of innovative products to prevent, diagnose, and treat dangerous bacterial infections, created by US and Wellcome in 2016.
  • Deutsche Stiftung Weltbevölkerung (DSW)coreStrategic or Co-development PartnerGlobal development organization focusing on needs of youth generation, committed to health information access and reproductive health initiatives with presence in Ethiopia, Kenya, Tanzania, and Uganda.
  • Doris Mollel FoundationcoreStrategic or Co-development PartnerFirst and only NGO in Tanzania working with government and private stakeholders for premature babies, having donated medical equipment worth $435,000+ and saved 13,000+ premature babies' lives.
  • Drugs for Neglected Diseases initiative (DNDi)flagshipStrategic or Co-development PartnerPatient-needs driven, not-for-profit R&D organization delivering new treatments for neglected diseases including leishmaniasis, sleeping sickness, Chagas disease, and pediatric HIV.
  • Elizabeth Glaser Pediatric AIDS FoundationcoreStrategic or Co-development PartnerProven leader in global fight to end HIV and AIDS with advocacy for children, having achieved significant progress through research, global advocacy, and health systems strengthening.
  • FHI 360coreStrategic or Co-development PartnerGlobal organization mobilizing resources and relationships for people to lead full and healthy lives, working in 60+ countries with local leaders to advance social and economic equity.
  • FINDcoreStrategic or Co-development PartnerGlobal alliance for diagnostics seeking to ensure equitable access to reliable diagnosis, working to save 1 million lives through accessible, quality diagnosis and save $1 billion in healthcare costs.
  • Georgia Global Health AlliancecoreStrategic or Co-development PartnerAlliance advancing global health equity by promoting collaboration among business, academia, nonprofits, and government within Georgia and linking them with US and international partners.
  • Global Antibiotic Research and Development Partnership (GARDP)flagshipStrategic or Co-development PartnerNot-for-profit organization developing new treatments for drug-resistant infections, created to ensure everyone who needs antibiotics receives effective and affordable treatment regardless of where they live.
  • Global Health CouncilcoreStrategic or Co-development PartnerEstablished in 1972, the leading membership organization supporting and connecting advocates, implementers, and stakeholders around global health priorities worldwide.
  • Global Health Innovative Technology Fund (GHIT)coreStrategic or Co-development PartnerJapan-based international public-private partnership between Japanese government, pharmaceutical companies, Gates Foundation, Wellcome, and UNDP, investing in neglected disease R&D.
  • Health 4 DevelopmentcoreStrategic or Co-development PartnerAfrican health sector knowledge powerhouse combining deep African roots with global reach, focusing on transforming Africa's private health sector for positive change.
  • IAVIcoreStrategic or Co-development PartnerGlobal not-for-profit ensuring development of safe, effective, accessible preventive HIV vaccines, working with partners in 25 countries to research, design, and develop AIDS vaccine candidates.
  • Impact Global Health (formerly Policy Cures Research)coreStrategic or Co-development PartnerNonprofit research and policy organization known for building the gold-standard G-FINDER database of global health R&D funding and comprehensive product pipeline datasets.
  • Infectious Disease AlliancecoreStrategic or Co-development PartnerGlobal network uniting civil society organizations committed to prevention, treatment, and control of infectious diseases, advocating for stronger policies and increased resources.
  • Infectious Diseases Society of America (IDSA)coreStrategic or Co-development PartnerOrganization of physicians, scientists, and health professionals dedicated to promoting health through excellence in infectious diseases research, education, and patient care.
  • Innovative Vector Control Consortium (IVCC)coreStrategic or Co-development PartnerProduct development partnership based in Liverpool working to facilitate development of novel public health insecticides to combat insecticide resistance in malaria-carrying mosquitoes.
  • International Partnership for MicrobicidescoreStrategic or Co-development PartnerDedicated to developing HIV prevention products and sexual and reproductive health technologies for women, making them available where urgently needed.
  • International Public Health Advisors (IPHA)coreStrategic or Co-development PartnerTeam with 27+ years working at intersection of international development, public health, and private sector, with 19 years active in malaria community.
  • International Vaccine Institute (IVI)coreStrategic or Co-development PartnerNonprofit intergovernmental organization established in 1997 with 36 countries and WHO on its treaty, focused on making vaccines available for world's most vulnerable.
  • Medicines for Malaria Venture (MMV)flagshipStrategic or Co-development PartnerLeading product development partnership in antimalarial drug R&D, working to reduce malaria burden through discovering, developing, and facilitating delivery of new antimalarial drugs.
  • Medicines Patent PoolcoreStrategic or Co-development PartnerFounded in 2010, working to increase access to and facilitate development of innovative medicines for low- and middle-income countries through voluntary licensing and patent pooling.
  • North Carolina Global Health AlliancecoreStrategic or Co-development PartnerAlliance dedicated to advancing North Carolina as a center of global health by fostering collaboration, innovation, and next-generation leadership in the state and region.
  • Pasteur FoundationcoreStrategic or Co-development PartnerUS partner of Institut Pasteur in Paris, a world-class biomedical research center with 10 Nobel Prizes, dedicated to studying and combating infectious diseases.
  • PATHflagshipStrategic or Co-development PartnerGlobal organization accelerating health equity by bringing together public institutions, businesses, social enterprises, and investors, developing and scaling solutions including vaccines, drugs, devices, and diagnostics.
  • Population CouncilcoreStrategic or Co-development PartnerConducts research to address critical health and development issues, helping people plan families, avoid HIV infection, and empowering girls, with work in 50+ countries.
  • Public CitizencoreStrategic or Co-development PartnerNonprofit consumer advocacy organization with 500,000 members and supporters, championing the public interest and defending democracy in halls of power.
  • Public Health Ambassadors UgandacoreStrategic or Co-development PartnerYouth-led nonprofit working on sexual and reproductive health and HIV/AIDS prevention through youth empowerment, health education, social entrepreneurship, and ICT for health.
  • Research!AmericacoreStrategic or Co-development PartnerAlliance advocating for science, discovery, and innovation to achieve better health, urging Congress to increase funding for NIH, CDC, FDA, and other agencies.
  • Sabin Vaccine InstitutecoreStrategic or Co-development PartnerLeading advocate for expanding vaccine access and uptake globally, advancing vaccine R&D, and amplifying vaccine knowledge, with two decades of experience.
  • South Africa Health Technologies Advocacy Coalition (SAHTAC)coreStrategic or Co-development PartnerCoalition advocating for enabling environment for health R&D and access to lifesaving technologies, supporting evidence-based policy change and improved funding coordination.
  • Speak Up AfricacoreStrategic or Co-development PartnerPolicy and advocacy action tank headquartered in Dakar, Senegal, dedicated to catalyzing leadership and policy change for sustainable development across Africa.
  • TB AllianceflagshipStrategic or Co-development PartnerNonprofit dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis through innovative science and global partnerships.
  • Treatment Action Group (TAG)coreStrategic or Co-development PartnerIndependent activist and community-based research and policy think tank committed to racial, gender, and LGBTQ+ equity and fighting to end HIV, TB, and hepatitis C.
  • Vizuri Health DynamicscoreStrategic or Co-development PartnerAfrican nonprofit created to foster competitive pharmaceutical manufacturing sector in Africa, partnering with regulators, purchasers, funders, and manufacturers.
  • Washington Global Health AlliancecoreStrategic or Co-development PartnerAlliance strategically connecting, expanding, and strengthening global health community to advance health equity, connecting 60+ organizational members across sectors.
  • Zebra Technologies International (formerly Temptime)coreStrategic or Co-development PartnerFor nearly 30 years, 10+ billion temperature monitoring devices have helped healthcare workers immunize children, working with WHO, UNICEF, Gavi, and US government to improve vaccine transport and storage.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Global Health Technologies Coalition competitors and assessment

Company assessment

Direct peers

  • Global Health Council: Founded in 1972, Global Health Council is a leading membership organization supporting advocates, implementers, and stakeholders around global health priorities. It is a direct peer — both are membership-driven US-based advocacy coalitions operating in the global health policy space, and GHTC is itself a member of GHC.
  • Research!America: Alliance advocating for science, discovery, and innovation to achieve better health by urging Congress to increase funding for NIH, CDC, FDA, and other agencies. Closely comparable as a US-focused advocacy coalition pushing for increased federal R&D funding — overlapping member ecosystems and advocacy targets with GHTC.
  • Sabin Vaccine Institute: Leading advocate for expanding vaccine access and uptake globally, advancing vaccine R&D, and amplifying vaccine knowledge. Comparable as a global health advocacy and product development organization with a strong US policy voice; current GHTC member.
  • Treatment Action Group (TAG): Independent activist and community-based research and policy think tank fighting to end HIV, TB, and hepatitis C. Comparable as a health R&D policy advocacy organization; a current GHTC member but also a peer in global health advocacy targeting similar policymakers.
  • Impact Global Health (formerly Policy Cures Research): Nonprofit research and policy organization behind the G-FINDER database tracking global health R&D funding. Direct peer — produces the evidence base GHTC uses for advocacy and operates in the same global health R&D policy ecosystem; current GHTC member.
  • American Society of Tropical Medicine and Hygiene (ASTMH): Largest international scientific organization dedicated to reducing the worldwide burden of tropical infectious diseases. Comparable as a global health R&D–adjacent membership/advocacy organization; a current GHTC member operating in adjacent scientific advocacy.

Regional players

  • Speak Up Africa: Policy and advocacy action tank headquartered in Dakar, Senegal, catalyzing leadership and policy change for sustainable development across Africa. Comparable as a health R&D advocacy organization focused on enabling environments and policy reform; current GHTC member.
  • Bay Area Global Health Alliance: Regional global health alliance with 70+ member organizations in the Bay Area. Comparable as a multi-stakeholder global health coalition model, though regionally focused; a current GHTC member and structural peer in coalition-based global health advocacy.
  • Washington Global Health Alliance: Alliance strategically connecting 60+ organizational members across sectors in the Pacific Northwest to advance health equity. Comparable multi-stakeholder global health coalition model with strong US policy and member engagement; a current GHTC member.

Broad incumbents

  • Public Citizen: Nonprofit consumer advocacy organization with 500,000+ members championing public interest issues including access to medicines and against pharmaceutical monopolies. Comparable in operating a US-focused policy advocacy coalition model, though much broader in scope than GHTC's global health R&D focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Global Health Technologies Coalition social profiles

Digital presence

Global Health Technologies Coalition financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Global Health Technologies Coalition leadership team

Management profile

Number of profiles

Profiles2 records

Global Health Technologies Coalition funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Global Health Technologies Coalition M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Health Technologies Coalition

What does Global Health Technologies Coalition do?

GHTC is a nonprofit advocacy coalition that brings together nonprofits, academic institutions, and aligned businesses to advocate for policy solutions that accelerate the development of vaccines, drugs, diagnostics, and other essential health technologies for global health needs. The coalition operates as PATH's secretariat program, offering policy advocacy, coalition coordination, member communications, and the Innovating for Impact Awards program to recognize partnerships and policymakers driving global health innovation.

Is Global Health Technologies Coalition a public or private company?

Global Health Technologies Coalition is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Global Health Technologies Coalition founded?

Global Health Technologies Coalition was founded in 2009. It employs 1 to 10 people.

Where is Global Health Technologies Coalition based?

Global Health Technologies Coalition is headquartered in Mississauga, Canada, in the North America region.

How does Global Health Technologies Coalition make money?

One revenue line is on record: coalition Operations.

Who are Global Health Technologies Coalition's main competitors?

Direct peers on record are Global Health Council, Research!America, Sabin Vaccine Institute, Treatment Action Group (TAG), Impact Global Health (formerly Policy Cures Research) and American Society of Tropical Medicine and Hygiene (ASTMH). Regional players are Speak Up Africa, Bay Area Global Health Alliance and Washington Global Health Alliance. Public Citizen is listed as a broad incumbent.

Does Global Health Technologies Coalition have an API?

No public API is recorded for Global Health Technologies Coalition.

What industry is Global Health Technologies Coalition in?

Global Health Technologies Coalition's product category is Health Policy Advocacy. Its primary akta.pro industry code is HLAJAOAD, Public–Private Partnerships (PPPs) for Global Health, with a secondary code of HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 8133 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals